TIANYIN PHARMACEUTICAL CO., INC. Earnings Per Share (Basic)
TIANYIN PHARMACEUTICAL CO., INC. reported Earnings Per Share (Basic) of -$0.04 per share for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-08-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2015-08-20
- TIANYIN PHARMACEUTICAL CO., INC. earnings per share, basic for the quarter ending 2015-03-31 was -$0.04.
- TIANYIN PHARMACEUTICAL CO., INC. earnings per share, basic for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- TIANYIN PHARMACEUTICAL CO., INC. earnings per share, basic for the quarter ending 2014-09-30 was $0.03, a 40.00% decline year-over-year.
- TIANYIN PHARMACEUTICAL CO., INC. earnings per share, basic for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- TIANYIN PHARMACEUTICAL CO., INC. earnings per share, basic for fiscal 2013 was $0.23, a 4.55% increase from fiscal 2012.
- TIANYIN PHARMACEUTICAL CO., INC. earnings per share, basic for fiscal 2012 was $0.22, a 60.00% decline from fiscal 2011.
- TIANYIN PHARMACEUTICAL CO., INC. earnings per share, basic for fiscal 2011 was $0.55.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2015-03-31 | -$0.04 10-Q · filed 2015-08-11 | $0.00 10-Q · filed 2015-08-11 | ||
| 2014-12-31 | $0.00 10-Q · filed 2015-08-20 | $0.04 10-Q · filed 2015-08-20 | ||
| 2014-09-30 | $0.03 10-Q · filed 2014-12-31 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-08-11 | $0.06 derived: net income ÷ weighted average shares · filed 2014-05-15 | $0.11 10-Q · filed 2015-08-11 | $0.18 derived: net income ÷ weighted average shares · filed 2014-05-15 |
| 2013-12-31 | $0.06 10-Q · filed 2015-08-20 | $0.11 10-Q · filed 2015-08-20 | $0.18 derived: net income ÷ weighted average shares · filed 2014-02-14 | $0.22 derived: net income ÷ weighted average shares · filed 2014-05-15 |
| 2013-09-30 | $0.05 10-Q · filed 2014-12-31 | $0.12 derived: net income ÷ weighted average shares · filed 2013-11-14 | $0.16 derived: net income ÷ weighted average shares · filed 2014-05-15 | $0.22 derived: net income ÷ weighted average shares · filed 2014-05-15 |
| 2013-06-30 | $0.07 derived: net income ÷ weighted average shares · filed 2013-09-26 | $0.11 derived: net income ÷ weighted average shares · filed 2014-05-15 | $0.17 derived: net income ÷ weighted average shares · filed 2014-05-15 | $0.23 10-K · filed 2013-09-26 |
| 2013-03-31 | $0.04 10-Q · filed 2014-05-15 | $0.11 derived: net income ÷ weighted average shares · filed 2014-05-15 | $0.16 10-Q · filed 2014-05-15 | $0.23 derived: net income ÷ weighted average shares · filed 2014-05-15 |
| 2012-12-31 | $0.06 10-Q · filed 2014-02-14 | $0.12 10-Q · filed 2014-02-14 | $0.19 derived: net income ÷ weighted average shares · filed 2014-02-14 | $0.22 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2012-09-30 | $0.05 10-Q · filed 2013-11-14 | $0.13 derived: net income ÷ weighted average shares · filed 2013-11-14 | $0.16 derived: net income ÷ weighted average shares · filed 2013-11-14 | $0.22 derived: net income ÷ weighted average shares · filed 2013-11-14 |
| 2012-06-30 | $0.08 derived: net income ÷ weighted average shares · filed 2013-09-26 | $0.11 derived: net income ÷ weighted average shares · filed 2013-09-26 | $0.16 derived: net income ÷ weighted average shares · filed 2013-09-26 | $0.22 10-K · filed 2013-09-26 |
| 2012-03-31 | $0.03 10-Q · filed 2013-05-15 | $0.09 derived: net income ÷ weighted average shares · filed 2013-05-15 | $0.14 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $0.06 10-Q · filed 2013-02-14 | $0.11 10-Q · filed 2013-02-14 | ||
| 2011-09-30 | $0.05 10-Q · filed 2012-11-14 | |||
| 2011-06-30 | $0.55 10-K · filed 2012-09-28 | |||
| 2011-03-31 | $0.14 10-Q · filed 2012-05-15 | $0.47 10-Q · filed 2012-05-15 | ||
| 2010-12-31 | $0.21 10-Q · filed 2012-02-13 | $0.33 10-Q · filed 2012-02-13 | ||
| 2010-09-30 | $0.12 10-Q/A · filed 2011-11-18 |